Trovagene has named Carlo Croce to serve on its scientific advisory board. Croce is director of the Human Cancer Genetics Program and the Genetics Institute at The Ohio State University, and he is John W. Wolfe Chair in Human Cancer Genetics.

Population Genetics has named Alan Schafer as its new CEO. Schafer is an adjunct professor at Imperial College London Business School and was previously the Wellcome Trust's director of science funding. Before that he served as global vice president of technology development at GlaxoSmithKline and co-founded Hexagen, a functional genomics company that was acquired by Incyte.

Pacific Biosciences said this week that Karen Bray has joined the company as VP of North American Sales. Bray previously was a sequencing sales leader at Life Technologies selling Ion Torrent and SOLiD systems in the Southeast and Mid-Atlantic regions, and before that she held sales posts at Beckman Coulter, Fisher Scientific, and Whatman.

More here:
Affy Says Genotyping Arrays a Bright Spot amid Q1 Revenue Drop; Plans to Close eBioscience Buy in Q2